Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.73 |
| ▸ | HCAR2 | Q8TDS4 | 6/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 4/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10389785 | 1.00 | ATM (0.73) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9510725 | 0.98 | HCAR2 (0.73) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL7190410 | 0.98 | HCAR2 (0.73) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL992108 | 0.98 | HCAR2 (0.73) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL992107 | 0.98 | HCAR2 (0.73) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9246661 | 0.98 | HCAR2 (0.73) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL7190405 | 0.98 | HCAR2 (0.73) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9510730 | 0.98 | HCAR2 (0.73) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL7193792 | 0.98 | HCAR2 (0.73) | ATMHCAR2MAPTRAB9ANPSR1 | |
| Dimethyl Fumarate SCHEMBL8992615 | 0.94 | ATM (0.83) | ATMHCAR2MAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220079884-A1 | PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX | BIOGEN SWISS MFG GMBH (CH) | 2022-03-17 | — | — | US | claimed |
| US-11229619-B2 | Controlled release pharmaceutical compositions comprising a fumaric acid ester | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2022-01-25 | — | — | US | claimed |
| US-20190201368-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2019-07-04 | — | — | US | claimed |
| US-20190117613-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2019-04-25 | — | — | US | claimed |
| CN-109044985-A | Pharmaceutical preparation comprising one of corrosion skeleton or a variety of fumarates | 前进制药知识产权有限公司 | 2018-12-21 | — | — | CN | claimed |
| US-20180325855-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | FWP IP APS (DK) | 2018-11-15 | — | — | US | claimed |
| US-20180263947-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2018-09-20 | — | — | US | claimed |
| US-20180221284-A1 | PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2018-08-09 | — | — | US | claimed |
| US-20180098957-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2018-04-12 | — | — | US | claimed |
| US-20180028483-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2018-02-01 | — | — | US | claimed |
| EP-2379063-A1 | PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX | Forward Pharma A/S (DK) | 2011-10-26 | — | — | EP | claimed |
| EP-2379062-A1 | PHARMACEUTICAL COMPOSITION COMPRISING ONE OR MORE FUMARIC ACID ESTERS | Forward Pharma A/S (DK) | 2011-10-26 | — | — | EP | claimed |
| WO-2010079222-A1 | PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX | FORWARD PHARMA A/S (DK) | 2010-07-15 | — | — | WO | claimed |
| WO-2010079221-A1 | PHARMACEUTICAL COMPOSITION COMPRISING ONE OR MORE FUMARIC ACID ESTERS | FORWARD PHARMA A/S (DK) | 2010-07-15 | — | — | WO | claimed |
| US-20090304790-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | ADITECH PHARMA AB (SE) | 2009-12-10 | — | — | US | claimed |
| US-20080299196-A1 | Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester | ADITECH PHARMA AB (SE) | 2008-12-04 | — | — | US | claimed |
| EP-1951206-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | Aditech Pharma AB (SE) | 2008-08-06 | — | — | EP | claimed |
| EP-1799196-A2 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | Aditech Pharma AB (SE) | 2007-06-27 | — | — | EP | claimed |
| WO-2007042034-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | ADITECH PHARMA AB (SE) | 2007-04-19 | — | — | WO | claimed |
| WO-2006037342-A2 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | ADITECH PHARMA AB (SE) | 2006-04-13 | — | — | WO | claimed |